HTDS (Hard to Treat Diseases) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Change In Payables And Accrued Expense?

Hard to Treat Diseases's Change In Payables And Accrued Expense for the quarter that ended in . 20 was $0.00 Mil. It means Hard to Treat Diseases's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Hard to Treat Diseases's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was $0.00 Mil. It means Hard to Treat Diseases's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Hard to Treat Diseases Change In Payables And Accrued Expense Historical Data

The historical data trend for Hard to Treat Diseases's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Change In Payables And Accrued Expense Chart

Hard to Treat Diseases Annual Data

Trend

Change In Payables And Accrued Expense

Hard to Treat Diseases Quarterly Data

Change In Payables And Accrued Expense

Hard to Treat Diseases Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Hard to Treat Diseases Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases Headlines

No Headlines